EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Emerging role of microRNAs as modulators of the tumor immune microenvironment

Rachele Frigerio, Arianna Ortolano, Gennaro Ciliberto, Rita Mancini, Luigi Fattore

Journal for ImmunoTherapy of Cancer · 2026-06 · 14 (6) · e014528

DOI: 10.1136/jitc-2025-014528 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 25.06.2026. Verfasst von Rachele Frigerio und 4 weiteren Autor:innen. Beteiligte Einrichtung: Magna Graecia University, Catanzaro, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Tumor Microenvironment, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Transcan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advent of immune checkpoint inhibitors (ICIs) has transformed the treatment landscape of several malignancies, but durable clinical benefits are only observed in a subset of patients. Primary and acquired resistance to immunotherapy, largely driven by an immunosuppressive tumor immune microenvironment (TIME), remains among the most critical hurdles to overcome. Amid the molecular regulators orchestrating immune evasion, tumor-derived microRNAs (miRNAs) have emerged as pivotal players. These small non-coding RNAs reshape the TIME through diverse mechanisms, including impairment of antigen presentation, modulation of immune checkpoint pathways, suppression of cytotoxic T and NK cell activity, induction of regulatory immune populations, and reprogramming of stromal and metabolic networks. This review explores the multifaceted contribution of miRNAs to ICI resistance and discusses innovative therapeutic strategies aimed at targeting dysregulated miRNAs, either through inhibition of oncomiRs or restoration of tumor-suppressors, with the goal of reprogramming the TIME toward an immunocompetent state. The clinical implementation of combination regimens of miRNA therapeutics with ICIs remains limited, highlighting the need to test these combinations in advanced preclinical models that faithfully recapitulate the human TIME. Such models could provide an optimal platform to integrate miRNA therapeutics into immuno-oncology strategies, ultimately expanding the benefits of ICIs to a broader patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsTumor MicroenvironmentNeoplasmsImmunotherapyHumansAnimalsImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

ImmunotherapyTumor microenvironment - TME

Substanzen

MicroRNAsImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Magna Graecia University, Catanzaro, Italy.
  • University of Rome La Sapienza, Rome, Italy.
  • Takis Srl, Rome, Italy gennaro54.ciliberto@gmail.com rita.mancini@uniroma1.it.
  • Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Rome, Italy gennaro54.ciliberto@gmail.com rita.mancini@uniroma1.it.
  • Scuola Superiore di Studi Avanzati Sapienza (SSAS), Rome, Italy.
  • Link Campus University, Rome, Italy.

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • Transcan

Zitieren

APA

Frigerio, R., Ortolano, A., Ciliberto, G., Mancini, R., & Fattore, L. (2026). Emerging role of microRNAs as modulators of the tumor immune microenvironment. Journal for ImmunoTherapy of Cancer, 14(6), e014528. https://doi.org/10.1136/jitc-2025-014528

Vancouver

Frigerio R, Ortolano A, Ciliberto G, Mancini R, Fattore L. Emerging role of microRNAs as modulators of the tumor immune microenvironment. Journal for ImmunoTherapy of Cancer. 2026;14(6):e014528. doi:10.1136/jitc-2025-014528

BibTeX
@article{Frigerio2026,
  author = {Frigerio, Rachele and Ortolano, Arianna and Ciliberto, Gennaro and Mancini, Rita and Fattore, Luigi},
  title = {Emerging role of microRNAs as modulators of the tumor immune microenvironment},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {6},
  pages = {e014528},
  doi = {10.1136/jitc-2025-014528}
}
Kostenlos starten →